Despite not being FDA approved for weight loss, Ozempic has undeniably become synonymous with slimming down
Combined with the short plasma half-life of injected GHK (minutes to ~2 hours before peptidase cleavage and copper redistribution to albumin/ceruloplasmin), this is why topical 12% serum beats subcutaneous injection for localized skin and scalp endpoints
Newer incretin-based medications like semaglutide and tirzepatide have changed obesity treatment by producing substantial weight loss, but their effects on neuropsychiatric health remain uncertain in routine clinical practice
These concerns led to a multistakeholder effort to develop a consensus on a change in nomenclature and the diagnostic criteria for the condition [7, 8]
These findings support the broader integration of GLP-1RAs into cardiovascular risk reduction strategies beyond glycaemic control
As a result, LC-MS remains one of the most trusted techniques for confirming the structure of therapeutic peptides